LZDT-10

N/A

Report date: 2022/01/10 10:59:52
NME

Base Information

Drug NameLZDT-10
Drug Alias NameLZDT-10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNorthwest A&F University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwest A&F University
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A